GLP-1 Receptor Agonists Linked to Rare Eye Complications in Diabetic Patients
A recent case series has reported nine patients who developed ophthalmic complications while using glucagon-like peptide 1 (GLP-1) receptor agonists semaglutide and tirzepatide. The most common complication was nonarteritic anterior ischemic optic neuropathy (NAION), with seven patients experiencing this condition. Researchers believe that rapid correction of hyperglycemia induced by these drugs may be associated with … Read more